Employees Retirement System of Texas’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Employees Retirement System of Texas’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107M	Sell	676,872 -11,400	-2%	-$1.54M	0.85%	29
2026 Q1	$87.9M	Sell	688,272 -37,000	-5%	-$4.62M	0.77%	33
2025 Q4	$88.4M	Sell	725,272 -13,000	-2%	-$1.49M	0.72%	35
2025 Q3	$74M	Sell	738,272 -115,100	-13%	-$10.4M	0.59%	43
2025 Q2	$70.8M	Sell	853,372 -13,800	-2%	-$1.1M	0.58%	44
2025 Q1	$70.3M	Sell	867,172 -10,100	-1%	-$903K	0.64%	35
2024 Q4	$79M	Buy	877,272 +220,400	+34%	+$21.4M	0.67%	34
2024 Q3	$64.9M	Buy	656,872 +53,015	+9%	+$5.21M	0.56%	51
2024 Q2	$56M	Buy	603,857 +174,857	+41%	+$15.7M	0.52%	61
2024 Q1	$40.7M	Buy	429,000 +53,000	+14%	+$4.92M	0.44%	81
2023 Q4	$33.6M	Hold	376,000	–	–	0.39%	88
2023 Q3	$27.5M	Buy	+376,000	New	+$30M	0.41%	79
2023 Q2	–	Sell	-89,000	Closed	-$6.78M	–	365
2023 Q1	$6.78M	Sell	89,000 -264,000	-75%	-$21.9M	0.1%	152
2022 Q4	$29.3M	Buy	+353,000	New	+$28.6M	0.43%	74
2022 Q3	–	Sell	-294,000	Closed	-$21.8M	–	687
2022 Q2	$21.8M	Buy	294,000 +71,000	+32%	+$5.33M	0.31%	81
2022 Q1	$20M	Hold	223,000	–	–	0.24%	107
2021 Q4	$25M	Buy	223,000 +34,000	+18%	+$4.1M	0.28%	87
2021 Q3	$23.8M	Sell	189,000 -26,000	-12%	-$3.35M	0.28%	91
2021 Q2	$29.1M	Buy	215,000 +38,000	+21%	+$5M	0.35%	61
2021 Q1	$24M	Buy	+177,000	New	+$26.5M	0.31%	76
2020 Q4	–	Sell	-160,000	Closed	-$17.8M	–	737
2020 Q3	$17.8M	Hold	160,000	–	–	0.26%	87
2020 Q2	$17.9M	Buy	160,000 +62,000	+63%	+$6.11M	0.27%	84
2020 Q1	$7.59M	Buy	98,000 +7,000	+8%	+$620K	0.14%	167
2019 Q4	$8.65M	Buy	91,000 +19,000	+26%	+$1.64M	0.13%	181
2019 Q3	$5.49M	Buy	+72,000	New	+$5.98M	0.09%	274

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Employees Retirement System of Texas's XBI Position: Q2 2026 in Review

Employees Retirement System of Texas reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.7% in Q2 2026, selling an estimated $1.54M and leaving 676,872 shares worth $107M. The position accounts for 0.85% of the portfolio, ranked #29.

Employees Retirement System of Texas first reported a position in XBI in Q3 2019 and has held it in 25 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Employees Retirement System of Texas held 676,872 shares of State Street SPDR S&P Biotech ETF worth $107M as of Q2 2026.
Employees Retirement System of Texas sold 11,400 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.54M.
State Street SPDR S&P Biotech ETF made up 0.85% of Employees Retirement System of Texas's portfolio in Q2 2026, its #29 holding.
Employees Retirement System of Texas first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and has held it in 25 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Employees Retirement System of Texas's 13F filing for Q2 2026, filed 14 Aug 2026.